Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

PSMD14 activates Neoplasm Metastasis. 5 / 5

| 1 4

➶

eidos

"This suggests that PSMD14 inhibition can suppress both growth and metastasis through SMAD3 induction and SLUG reduction ."

| PMC

➶

reach

"Deubiquitinase PSMD14 Enhances Hepatocellular Carcinoma Growth and Metastasis by Stabilizing GRB2."

31634528

➶

reach

"This suggests that PSMD14 inhibition can suppress both growth and metastasis through SMAD3 induction and SLUG reduction."

| PMC

➶

reach

"Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma."

29331416

➶

reach

"Furthermore, in vivo assays show that knockdown of PSMD14 inhibits the growth, lung and abdominal metastasis of ovarian cancer."

36328147

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

PSMD14 activates Neoplasm Metastasis. 5 / 5

Our Sources:

Databases

Reading